Fumonisin-induced blockade of ceramide synthase in sphingolipid biosynthetic pathway alters aortic input impedance spectrum of pigs

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Constable, Peter D ^a   Smith, Geoffrey W ^a   Rottinghaus, George E ^a   Tumbleson, Mike E ^b   Haschek, Wanda M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Afterload; Sphinganine; Sphingosine; Tumor necrosis factor

Indexed keywords

CHLORALOSE; FUMONISIN; FUMONISIN B1; SPHINGANINE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE ACYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; AORTA; AORTA FLOW; AORTA PRESSURE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; CORN; ENZYME INHIBITION; HEART OUTPUT; IMPEDANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; SIGNAL TRANSDUCTION; SWINE; SYSTEMIC VASCULAR RESISTANCE;

EID: 0038782034     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00155.2002     Document Type: Article

References (42)

1. Alexander J, Burkhoff D, Schipke J, and Sagawa K. Influence of mean pressure on aortic impedance and reflections in the systemic arterial system. Am J Physiol Heart Circ Physiol 257: H969-H978, 1989.
2. Arden WA, Fiscus RR, Wang X, Maley R, Lanzo S, and Gross DR. Early endotoxic shock results in enhanced vasodilator responses to nitroglycerin but unaltered responses to neuropeptides calcitonin gene-related peptide and substance P. Shock 1: 425-431, 1994.
3. Chao CP, Laulederkind SJF, and Ballou LR. Sphingosinemediated phosphatidylinositol metabolism and calcium mobilization. J Biol Chem 269: 5849-5856, 1994.
4. Constable PD. Acute endotoxemia increases left ventricular contractility and diastolic stiffness in calves. Shock 12: 391-401, 1999.
5. Constable PD, Smith GW, Rottinghaus GE, and Haschek WM. Ingestion of fumonisin Bl-containing culture material decreases cardiac contractility and mechanical efficiency in swine. Toxicol Appl Pharmacol 162: 151-160, 2000.
6. Fredrickson RL, Constable PD, Smith GW, Tumbleson ME, Eppley RM, and Haschek WM. Sphingolipid changes and pathology in Sinclair minipigs fed low levels of fumonisin B1 for six months (Abstract). Toxicol Sci 66: 7, 2002.
7. Ghosh TK, Bian J, and Gill DL. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science 248: 1653-1656, 1990.
8. Ghosh TK, Bian J, and Gill DL. Sphingosine-1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. J Biol Chem 269: 22628-22635, 1994.
9. Glembot TM, Britt LD, and Hill MA. Endotoxin interacts with tumor necrosis factor-α to induce vasodilation of isolated rat skeletal muscle arterioles. Shock 5: 251-257, 1996.
10. Gumprecht LA, Smith GW, Constable PD, and Haschek WM. Species and organ specificity of fumonisin-induced endothelial alterations: potential role in porcine pulmonary edema. Toxicology 160: 71-79, 2001.
11. Haschek WM, Gumprecht LA, Smith GW, Tumbleson ME, and Constable PD. Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives. Environ Health Perspect 109, Suppl 2: 251-257, 2001.
12. Haschek WM, Motelin G, Ness DK, Harlin KS, Hall WF, Vesonder RF, Peterson RE, and Beasley VR. Characterization of fumonisin toxicity in orally and intravenously dosed swine. Mycopathologia 117: 83-96, 1992.
13. Hsiao SH, Constable PD, Smith GW, and Haschek WM. Effects of sphingosine, sphinganine, and sphingosine-1-phosphate on phenylephrine contracted porcine thoracic aorta and intrapulmonary artery rings (Abstract). Toxicol Sci 60, Suppl: 13-14, 2001.
14. Jayadev S, Linardic CM, and Hannun YA. Identification of arachadonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor-α. J Biol Chem 269: 5757-5763, 1994.
15. Johns DG, Jin J, Wilde DW, and Webb RC. Ceramideinduced vasorelaxation. An inhibitory action on protein kinase C. Gen Pharmacol 33: 415-421, 1999.
16. Johns DG, Osborn H, and Webb RC. Ceramide: a novel cell signaling mechanism for vasodilation. Biochem Biophys Res Commun 237: 95-97, 1997.
17. 2-dependent ceramide signaling. Am J Physiol Heart Circ Physiol 275: H1592-H1598, 1998.
18. 1 receptor in rat small artery. Am J Physiol Heart Circ Physiol 282: H175-H183, 2002.
19. Laskey WK, Kussmaul WG, Martin JL, Kleaveland JP, Hirshfeld JW Jr, and Shroff S. Characteristics of vascular hydraulic load in patients with heart failure. Circulation 72: 61-71, 1985.
20. ca channel activity and vascular tone in coronary arteries. Hypertension 33: 1441-1446, 1999.
21. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol Regul Integr Comp Physiol 274: R577-R595, 1998.
22. Murohara T, Kugiyama K, Ohgushi M, Sugitama S, Ohta Y, and Yasue H. Effects of sphingomyelinase and sphingosine on arterial vasomator regulation. J Lipid Res 37: 1601-1608, 1996.
23. Nelson MT, Patlak JB, Worley JF, and Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol Cell Physiol 259: C3-C18, 1990.
24. Nichols WW and O'Rourke MF. McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles (4th ed.). London: Oxford University Press, 1998, p. 1-564.
25. Nichols WW and Paley DM. Experimental evaluation of a multisensor velocity-pressure catheter. Med Biol Eng Comput 23: 79-83, 1985.
26. O'Rourke MF. Vascular impedance in studies of arterial and cardiac function. Physiol Rev 62: 570-623, 1982.
27. Pepine CJ, Nichols WW, Curry RC, and Conti CR. Aortic input impedance during nitroprusside infusion: a reconsideration of afterload reduction and beneficial action. J Clin Invest 64: 643-654, 1979.
28. Riley RT, An NH, Showker JL, Yoo HS, Norred WP, Chamberlain WJ, Wang E, Merrill AH Jr, Motelin G, Beasley VR, and Haschek WM. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol Appl Pharmacol 118: 105-112, 1993.
29. Sabbadini RA, Betto R, Teresi A, Fachechi-Cassano G, and Salviati G. The effects of sphingosine on sarcoplasmic reticulum membrane calcium release. J Biol Chem 267: 15475-15484, 1992.
30. Sabbah HN, Przybylski J, Albert DE, and Stein PD. Peak aortic blood acceleration reflects the extent of left ventricular ischemic mass at risk. Am Heart J 113: 885-890, 1987.
31. Shibata M, Parfenova H, Zuckerman SL, and Leffler CW. Tumor necrosis factor-α induces pial arteriolar dilation in newborn pigs. Brain Res Bull 39: 241-247, 1996.
32. 1 decreases cardiovascular function but does not alter pulmonary capillary permeability in swine. Toxicol Sci 56: 240-249, 2000.
33. 1 in horses. Am J Vet Res 63: 538-545, 2002.
34. Smith GW, Constable PD, and Haschek WM. Cardiovascular responses to short-term fumonisin exposure in swine. Fundam Appl Toxicol 33: 140-148, 1996.
35. Smith GW, Constable PD, Tumbleson ME, Rottinghaus GE, and Haschek WM. Sequence of cardiovascular changes leading to pulmonary edema in swine fed culture material containing fumonisin. Am J Vet Res 60: 1292-1300, 1999.
36. Tosaka M, Okajima F, Hashiba Y, Saito N, Nagano T, Watanabe T, Kimura T, and Sasaki T. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo. Possible role in pathogenesis of cerebral vasospasm. Stroke 32: 2913-2919, 2001.
37. Van den Bos GC, Westerhof N, and Randall OS. Pulse wave reflection: can it explain the differences between systemic and pulmonary pressure and flow waves: a study in dogs. Circ Res 51: 479-485, 1982.
38. Wang E, Norred WP, Bacon CW, Riley RT, and Merrill AH Jr. Inhibition of sphingosine biosynthesis by fumonisins: implications for diseases associated with Fusarium moniliforme. J Biol Chem 266: 14486-14490, 1991.
39. 1 levels associated with an epizootic of equine leukoencephalomalacia. J Vet Diagn Invest 2: 213-216, 1990.
40. Yin FCP, Weisfeldt ML, and Milnor WR. Role of aortic impedance in the decreased cardiovascular response to exercise with aging in dogs. J Clin Invest 68: 28-38, 1981.
41. i in rat aortic smooth muscle. Lipids 34: 689-695, 1999.
42. i in canine cerebral vascular muscle. Am J Physiol Heart Circ Physiol 278: H1421-H1428, 2000.